Teriflunomide as precipitating factor of renal failure in a patient with relapsing-remitting multiple sclerosis and focal segmental glomerulosclerosis

Mult Scler Relat Disord. 2020 Nov:46:102506. doi: 10.1016/j.msard.2020.102506. Epub 2020 Sep 20.

Authors

Vincenzo Dattola¹, Sara Gasparini², Damiano Branca³, Anna Lisa Logiudice⁴, Margherita Russo⁴, Vittoria Cianci³, Umberto Aguglia²

Affiliations

¹ Neurologic Unit, Great Metropolitan Hospital of Reggio Calabria, Italy. Electronic address: vincenzo.dattola@gmail.com.
² Regional Epilepsy Centre, Great Metropolitan Hospital of Reggio Calabria, Italy; Department of Medical and Surgical Sciences, Magna Greacia University of Catanzaro, Italy.
³ Neurologic Unit, Great Metropolitan Hospital of Reggio Calabria, Italy.
⁴ IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy.

PMID: 32979731
DOI: 10.1016/j.msard.2020.102506

No abstract available

Keywords: Adverse event; Focal segmental glomerulosclerosis; Multiple sclerosis; Renal failure; Teriflunomide.

Publication types

Letter

MeSH terms

Crotonates / adverse effects
Glomerulosclerosis, Focal Segmental* / complications
Glomerulosclerosis, Focal Segmental* / drug therapy
Humans
Hydroxybutyrates
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting* / complications
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
Nitriles
Precipitating Factors
Renal Insufficiency*
Toluidines

Substances

Crotonates
Hydroxybutyrates
Nitriles
Toluidines
teriflunomide